...
机译:阿昔洛韦对早期HIV1感染期间单纯疱疹病毒2型血清反应阳性者HIV-1设定点的影响
Department of Medicine, Schools of Medicine and Public Health, University of Washington, Seattle;
The Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington;
The Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington;
Department of Medicine, Schools of Medicine and Public Health, University of Washington, Seattle|Department of Laboratory Medicine, Schools of Medicine and Public Health, University of Washington, Seattle;
Asociacion Civil Impacta Salud y Educacion (IMPACTA), Lima, Peru;
Department of Medicine, University of Alabama at Birmingham, Birmingham|Centre for Infectious Disease Research in Zambia, Lusaka, Zambia;
Reproductive Health Unit, University of Witswatersrand, Johannesburg, South Africa;
University College London, London, United Kingdom;
San Francisco Dep;
机译:在早期HIV-1感染期间,无环鸟苷对2型单纯疱疹病毒阳性患者中HIV-1设定点的影响。
机译:单纯疱疹病毒2型血清反应阳性者感染人类免疫缺陷病毒的风险:一项荟萃分析。
机译:用阿昔洛韦或伐昔洛韦进行的2型单纯疱疹病毒抑制治疗未针对双重感染HIV-1 / HSV-2的患者选择特定的HIV-1抗药性。
机译:诱导诱导的Acyclovir耐药疱疹病毒型肾小序激酶基因的氨基酸取代1
机译:1型和2型单纯疱疹病毒(HSV-1和HSV-2),巨细胞病毒(CMV),爱泼斯坦巴尔病毒(EBV),人乳头瘤病毒(HPV),沙眼衣原体,淋病奈瑟氏球菌感染和先兆子痫之间的关联。
机译:用阿昔洛韦或伐昔洛韦单纯疱疹病毒2型抑制治疗不能选择双重感染HIV-1 / HSV-2的特定HIV-1耐药性。
机译:用阿昔洛韦或伐昔洛韦单纯疱疹病毒2型抑制疗法不能选择双重感染HIV-1 / HSV-2的特定HIV-1抵抗力。